Natco Pharma Q2FY25 results: PAT jumps 83% to Rs 676 cr on robust sales

Q: How long will it take to read this news story?

The story "Natco Pharma Q2FY25 results: PAT jumps 83% to Rs 676 cr on robust sales" has 208 words across 8 sentences, which will take approximately 1 - 2 minutes for the average person to read.

Q: Which news outlet covered this story?

The story "Natco Pharma Q2FY25 results: PAT jumps 83% to Rs 676 cr on robust sales" was covered 1 weeks ago by Business Standard, a news publisher based in India.

Q: How trustworthy is 'Business Standard' news outlet?

Business Standard is a fully independent (privately-owned) news outlet established in 1975 that covers mostly business and finance news. The outlet is headquartered in India and publishes an average of 300 news stories per day. It's most recent story was published 3 hours ago.

Q: What do people currently think of this news story?

The sentiment for this story is currently Neutral, indicating that people are not responding positively or negatively to this news.

Q: How do I report this news for inaccuracy?

You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.<ul><li>News ID: #23554276</li><li>URL: https://beamstart.com/news/natco-pharma-q2fy25-results-pat-17314172066117</li></ul>

Business Standard Logo Business Standard 1w ago

Natco Pharma Q2FY25 results: PAT jumps 83% to Rs 676 cr on robust sales - Business Standard

Quick Summary:

Natco Pharma on Tuesday said its consolidated net profit jumped 83 per cent on-year to Rs 676 crore in the September 2024 quarter, aided by robust sales.

"The company has shown continued strong growth during the second quarter driven by exports formulation business and stable domestic pharmaceutical business," it stated.

Revenue from operations rose to Rs 1,371 crore as compared with Rs 1,031 crore in the year-ago period, the company said in a regulatory filing.